The global health care and life sciences industries are changing rapidly due to advances in research and technology, with worldwide spending projected to surpass $10 trillion in 2022. This rapid growth has major implications for established organizations and emerging startups alike, increasing the need for professionals who understand the science driving the future of health care.
In response to this increasing need for medical science knowledge across a broad range of job roles, Harvard Medical School is launching HMX Pro, a new series of online courses designed for working professionals in health care and in the life sciences that will cover advances in fields like genetics, immunology and pharmacology. HMX launched its initial online programs, HMX Fundamentals, in 2015.
“While delivering HMX courses to learners around the world, we’ve seen significant interest from professionals in a variety of roles who want to enhance their understanding of medical science to take on new challenges,” said Michael Parker, associate dean for online learning at HMS and faculty director of HMX.
The learner community includes science and business professionals from companies like Celgene, Bristol Myers-Squibb, Janssen, and Merck. Companies including Google, Novartis and Moderna Therapeutics have offered the courses to groups of their employees to emphasize the role of learning in keeping pace with change.
“HMX gives us the opportunity to meet the need for more medical training and more awareness about medical topics,” said Irene Nyavor, program manager at Google, who helped to bring the courses to employees.
“I’ve found all the courses to be tremendously helpful,” said Siyan Xu, senior principal biostatistician at Novartis. “They are challenging in a positive way.”
The new HMX Pro courses were developed for those who want to get up to speed on emerging topics in medical science for specific projects, applications or research, with learners ranging from scientists taking on new research areas to business leaders who want to better understand their products and more effectively collaborate across disciplines.
The initial courses cover key topics that are transforming health care, including cancer genomics and immuno-oncology.
“Advances in genetics and immunology have significantly changed cancer diagnosis and treatment,” said Parker. “Anyone whose work intersects with cancer needs to understand the science driving these cutting-edge applications.”
Advanced HMX Pro courses such as cancer genomics and immuno-oncology are intended for learners with some background in the underlying topic; those who require an introduction can opt to take additional courses that provide the key knowledge needed to get the most out of the experience.
As with all HMX courses, the HMX Pro series incorporates the latest advances in learning science to provide an engaging experience led by HMS faculty. Each lesson includes whiteboard-style videos and detailed animations, with concepts reinforced by interactive elements, true-to-life scenarios and real patient cases to enhance learning.
Hope flags when medications fail, isolating and endangering patients. Backed by a major grant, 2 Harvard scientists are focused on reducing the distance between diagnosis and recovery.
Gift from business leader Alfred Lin ’94 and artist Rebecca Lin ’94, part of record 30th reunion giving, builds on critical new efforts on dialogue and generative AI
Featured series 
